How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
33
GSBD Quote, Financials, Valuation and Earnings
Last price:
$11.63
Seasonality move
:
1.9%
Day range:
$11.39 - $11.90
52-week range:
$11.39 - $15.94
Dividend yield:
14.36%
P/E ratio:
20.40x
P/S ratio:
16.94x
P/B ratio:
0.87x
Volume:
1.1M
Avg. volume:
845.9K
1-year change:
-22.36%
Market cap:
$1.4B
Revenue:
$78.7M
EPS (TTM):
$0.57
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $146.6M | $170.1M | $56.6M | $208M | $78.7M | |
| Revenue Growth (YoY) | 238.64% | 16.03% | -66.7% | 267.22% | -62.16% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | $7.6M | $8.7M | $8.6M | $10.4M | |
| Other Inc / (Exp) | -$43.7M | $39.6M | -$18.7M | -$71.8M | -$158.7M | |
| Operating Expenses | -$31M | -$24M | -$3.1M | $6.6M | $10.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $177.5M | $194.1M | $59.7M | $201.4M | $68.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4M | $1.6M | $4.7M | $5.5M | $5.5M | |
| Net Income to Company | $176.1M | $192.4M | $55M | $195.9M | $62.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $176.1M | $192.4M | $55M | $195.9M | $62.9M | |
| Basic EPS (Cont. Ops) | $3.26 | $1.89 | $0.54 | $1.81 | $0.55 | |
| Diluted EPS (Cont. Ops) | $3.26 | $1.89 | $0.54 | $1.81 | $0.55 | |
| Weighted Average Basic Share | $53.9M | $101.7M | $102.3M | $108.3M | $114.7M | |
| Weighted Average Diluted Share | $53.9M | $101.7M | $102.3M | $108.3M | $114.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $217.4M | $253.1M | $139.2M | $312.7M | $182.1M | |
| Revenue (Reported) | $146.6M | $170.1M | $56.6M | $208M | $78.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $217.4M | $253.1M | $139.2M | $312.7M | $182.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $142.3M | $33.9M | $8.1M | $54.3M | $42.1M | |
| Revenue Growth (YoY) | 1237.61% | -76.15% | -76.21% | 572.74% | -22.43% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.7M | $2M | $2.2M | $2M | $2.9M | |
| Other Inc / (Exp) | $3.7M | -$771K | -$11.8M | -$27.4M | -$25.2M | |
| Operating Expenses | -$30.7M | -$5.4M | $2.2M | $2M | $2.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $173M | $39.4M | $5.9M | $52.3M | $39.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $334K | $404K | $2.2M | $1.7M | $1.6M | |
| Net Income to Company | $172.6M | $39M | $3.7M | $50.6M | $37.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $172.6M | $39M | $3.7M | $50.6M | $37.5M | |
| Basic EPS (Cont. Ops) | $1.70 | $0.38 | $0.04 | $0.46 | $0.33 | |
| Diluted EPS (Cont. Ops) | $1.70 | $0.38 | $0.04 | $0.46 | $0.33 | |
| Weighted Average Basic Share | $101.5M | $101.8M | $102.8M | $109.6M | $117.3M | |
| Weighted Average Diluted Share | $101.5M | $101.8M | $102.8M | $109.6M | $117.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $186M | $54.4M | $31.5M | $80.3M | $66.9M | |
| Revenue (Reported) | $142.3M | $33.9M | $8.1M | $54.3M | $42.1M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $186M | $54.4M | $31.5M | $80.3M | $66.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $146.6M | $170.1M | $56.6M | $208M | $78.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | $7.6M | $8.7M | $8.6M | $10.4M | |
| Other Inc / (Exp) | -$43.7M | $39.6M | -$18.7M | -$71.8M | -$158.7M | |
| Operating Expenses | -$31M | -$24M | -$3.1M | $6.6M | $10.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $177.5M | $194.1M | $59.7M | $201.4M | $68.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4M | $1.6M | $4.7M | $5.5M | $5.5M | |
| Net Income to Company | $176.1M | $192.4M | $55M | $195.9M | $62.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $176.1M | $192.4M | $55M | $195.9M | $62.9M | |
| Basic EPS (Cont. Ops) | $1.78 | $1.89 | $0.54 | $1.80 | $0.57 | |
| Diluted EPS (Cont. Ops) | $1.78 | $1.89 | $0.54 | $1.80 | $0.57 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $217.4M | $253.1M | $139.2M | $312.7M | $182.1M | |
| Revenue (Reported) | $146.6M | $170.1M | $56.6M | $208M | $78.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $217.4M | $253.1M | $139.2M | $312.7M | $182.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $170.1M | $56.6M | $208M | $78.7M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.6M | $8.7M | $8.6M | $10.4M | -- | |
| Other Inc / (Exp) | $39.6M | -$18.7M | -$71.8M | -$158.7M | -- | |
| Operating Expenses | -$24M | -$3.1M | $6.6M | $10.4M | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $194.1M | $59.7M | $201.4M | $68.3M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.6M | $4.7M | $5.5M | $5.5M | -- | |
| Net Income to Company | $192.4M | $55M | $195.9M | $62.9M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $192.4M | $55M | $195.9M | $62.9M | -- | |
| Basic EPS (Cont. Ops) | $1.89 | $0.54 | $1.80 | $0.57 | -- | |
| Diluted EPS (Cont. Ops) | $1.89 | $0.54 | $1.80 | $0.57 | -- | |
| Weighted Average Basic Share | $406.8M | $409M | $433.2M | $458.7M | -- | |
| Weighted Average Diluted Share | $406.8M | $409M | $433.2M | $458.7M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $253.1M | $139.2M | $312.7M | $182.1M | -- | |
| Revenue (Reported) | $170.1M | $56.6M | $208M | $78.7M | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $253.1M | $139.2M | $312.7M | $182.1M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $32.1M | $33.8M | $39.6M | $52.4M | $61.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $56.3M | $57.1M | $71.4M | $90.9M | $89.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $3.2B | $3.5B | $3.5B | $3.4B | $3.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.3B | $3.6B | $3.6B | $3.5B | $3.6B | |
| Accounts Payable | $55.9M | $60.8M | $59.6M | $62.7M | $74.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $64.5M | $69.9M | $68.7M | $84.4M | $89.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7B | $1.9B | $2.1B | $1.9B | $2B | |
| Common Stock | $102K | $102K | $103K | $110K | $117K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.6B | $1.6B | $1.5B | $1.6B | $1.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.6B | $1.6B | $1.5B | $1.6B | $1.6B | |
| Total Liabilities and Equity | $3.3B | $3.6B | $3.6B | $3.5B | $3.6B | |
| Cash and Short Terms | $32.1M | $33.8M | $39.6M | $52.4M | $61.8M | |
| Total Debt | $1.6B | $1.9B | $2B | $1.8B | $1.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $32.1M | $33.8M | $39.6M | $52.4M | $61.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $56.3M | $57.1M | $71.4M | $90.9M | $89.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $3.2B | $3.5B | $3.5B | $3.4B | $3.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.3B | $3.6B | $3.6B | $3.5B | $3.6B | |
| Accounts Payable | $55.9M | $60.8M | $59.6M | $62.7M | $74.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $64.5M | $69.9M | $68.7M | $84.4M | $89.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7B | $1.9B | $2.1B | $1.9B | $2B | |
| Common Stock | $102K | $102K | $103K | $110K | $117K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.6B | $1.6B | $1.5B | $1.6B | $1.6B | |
| Total Liabilities and Equity | $3.3B | $3.6B | $3.6B | $3.5B | $3.6B | |
| Cash and Short Terms | $32.1M | $33.8M | $39.6M | $52.4M | $61.8M | |
| Total Debt | $1.6B | $1.9B | $2B | $1.8B | $1.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $176.1M | $192.4M | $55M | $195.9M | $62.9M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$4.1M | $826K | -$8.5M | -$6.8M | $10.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $165.8M | -$29.9M | $27.4M | $300.7M | $2.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$145.6M | -$193M | -$180M | -$191M | -$197.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $1.1B | $846.2M | $378.5M | $1.1B | |
| Long-Term Debt Repaid | -$1.3B | -$898.2M | -$698.5M | -$567.7M | -$995.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$143.1M | $31.7M | -$21.7M | -$288M | $7.1M | |
| Beginning Cash (CF) | $9.4M | $32.1M | $33.8M | $39.6M | $52.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $22.7M | $1.8M | $5.7M | $12.7M | $9.6M | |
| Ending Cash (CF) | $32.1M | $33.8M | $39.6M | $52.4M | $61.8M | |
| Levered Free Cash Flow | $165.8M | -$29.9M | $27.4M | $300.7M | $2.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $60.5M | $40.2M | $28.1M | $42.5M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$2M | $2.4M | $1.6M | $320K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $100M | $39.3M | $32.3M | $7M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$49.6M | -$44.6M | -$44.6M | -$47.6M | -- | |
| Special Dividend Paid | $50K | -- | -- | -- | $160K | |
| Long-Term Debt Issued | $130.6M | $131.8M | $68.9M | $502.6M | -- | |
| Long-Term Debt Repaid | -$167M | -$129M | -$147M | -$491M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$86.5M | -$41.8M | -$24.7M | -$7M | -- | |
| Beginning Cash (CF) | $32.1M | $33.8M | $39.6M | $52.4M | -- | |
| Foreign Exchange Rate Adjustment | -$129K | $89K | $11K | -$73K | -- | |
| Additions / Reductions | $13.5M | -$2.4M | $7.6M | $29K | -- | |
| Ending Cash (CF) | $45.5M | $31.4M | $47.2M | $52.3M | -- | |
| Levered Free Cash Flow | $100M | $39.3M | $32.3M | $7M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $176.1M | $192.4M | $55M | $195.9M | $62.9M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$4.1M | $826K | -$8.5M | -$6.8M | $10.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $165.8M | -$29.9M | $27.4M | $300.7M | $2.5M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$145.6M | -$193M | -$180M | -$191M | -$197.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $1.1B | $846.2M | $378.5M | $1.1B | |
| Long-Term Debt Repaid | -$1.3B | -$898.2M | -$698.5M | -$567.7M | -$995.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$143.1M | $31.7M | -$21.7M | -$288M | $7.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $22.7M | $1.8M | $5.7M | $12.7M | $9.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $165.8M | -$29.9M | $27.4M | $300.7M | $2.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $60.5M | $40.2M | $28.1M | $42.5M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$2M | $2.4M | $1.6M | $320K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $100M | $39.3M | $32.3M | $7M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$49.6M | -$44.6M | -$44.6M | -$47.6M | -- | |
| Special Dividend Paid | $50K | -- | -- | -- | $160K | |
| Long-Term Debt Issued | $130.6M | $131.8M | $68.9M | $502.6M | -- | |
| Long-Term Debt Repaid | -$167M | -$129M | -$147M | -$491M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$86.5M | -$41.8M | -$24.7M | -$7M | -- | |
| Beginning Cash (CF) | $32.1M | $33.8M | $39.6M | $52.4M | -- | |
| Foreign Exchange Rate Adjustment | -$129K | $89K | $11K | -$73K | -- | |
| Additions / Reductions | $13.5M | -$2.4M | $7.6M | $29K | -- | |
| Ending Cash (CF) | $45.5M | $31.4M | $47.2M | $52.3M | -- | |
| Levered Free Cash Flow | $100M | $39.3M | $32.3M | $7M | -- | |
Get GSBD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GSBD
Sector
P/E ratio
20.40x
11.44x
PEG ratio
13.96x
0.38x
P/B ratio
0.87x
1.07x
Price / LTM sales
16.94x
2.47x
Growth Metrics
GSBD
Sector
Revenue growth
-22.43%
6.9%
Earnings growth
-28.26%
7.04%
Revenue (5-year growth)
12.7%
5.27%
Earnings forecast
$0.46
$0.57
Profitability
GSBD
Sector
Profitability FY 2025
--
$159.4M
Return on invested capital
1.81%
5.51%
Return on assets
1.76%
0.99%
Return on equity
3.94%
9.5%
Earnings Date
Last Earnings Date
Feb
27
Next Earnings Date
May
8
Estimated Next Earnings Date
May
29
Balance Sheet
GSBD
Sector
Total cash
$61.8M
$471.6M
Short term investments
--
$263.5M
Total assets
$3.6B
$4.4B
Long term debt
$1.9B
$343.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
